Savers Value Village Inc — Current Report (Form 8-K)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 13, 2026

Savers Value Village, Inc.

(Exact name of Registrant as specified in its charter)

11400 S.E. 6th Street, Suite 125

Bellevue, WA 98004

(Address of principal executive offices)

(425) 462-1515

(Registrant’s telephone number, including area code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

On August 11, 2026, Savers Value Village, Inc. (the “Company”) and certain Ares Private Equity and Opportunistic Credit funds and accounts (the “Selling Stockholders”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Jefferies LLC and UBS Securities LLC, as representatives of the several underwriters named in Schedule 1 thereto (collectively, the “Underwriters”), for the sale of 23,000,000 shares of common stock, par value $0.000001, of the Company (the “Common Stock”), at a price to the public of $10.25 per share (the “Offering”). The Offering was completed on August 13, 2026. The Company did not receive any proceeds from the sale of shares of Common Stock by the Selling Stockholders in the Offering.

Also pursuant to the Underwriting Agreement, the Company purchased from the Underwriters 1,021,580 shares of Common Stock sold by the Selling Stockholders in the Offering, at a purchase price equal to the price at which the Underwriters purchased the shares of Common Stock from the Selling Stockholders (the “Concurrent Share Repurchase”). The Company used existing cash on hand to fund the Concurrent Share Repurchase.

The Offering was made pursuant to a shelf registration statement on Form S-3 (File No. 333-287208) filed with the Securities and Exchange Commission (the “SEC”) and which became effective on May 14, 2025 (the “Registration Statement”), a prospectus, dated May 13, 2025 included as part of the Registration Statement and a prospectus supplement, dated August 11, 2026 and filed with the SEC on August 13, 2026. The foregoing description of the terms in the Underwriting Agreement is qualified in its entirety by reference to the Underwriting Agreement, which is attached hereto as Exhibit 1.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized this 13th day of August, 2026.